WJCD  Vol.3 No.8 , November 2013
Hepatitis E is more common than hepatitis A among returning travellers presenting to tertiary care

Introduction: Acute viral hepatitis is a relatively common infection resulting in hospital attendance after foreign travel. Travellers and doctors are generally aware of hepatitis A and the fact that safe and effective immunisation is available. In contrast, there is no widely available vaccine for hepatitis E and most physicians’ experience with this condition is limited. Over the last few years, the number of cases of hepatitis E has increased. Methods: We examined the prevalence of hepatitis A and E among patients presenting to the Hospital for Tropical Diseases between 2000 and 2009. Travel history, demographics and laboratory parameters of these patients were compared. Results: The annual incidence of hepatitis A remained static, while that of hepatitis E increased from 1 to 4. Hepatitis E was associated with older age, travel to the Indian sub-continent (ISC), and visiting friends and relatives (VFR). Peak ALT was similar between patients with hepatitis A or E, but as many as a third of those with hepatitis E developed a prolonged INR, compared to 11% of those with hepatitis A. In addition, patients with hepatitis E had a longer hospital admission by a median of 3 days. Conclusion: Hepatitis E is now the commonest cause of faeco-oral viral hepatitis at this centre, and is associated with laboratory features suggestive of more severe liver damage and longer hospital stay.


Cite this paper
Cosgrove, C. , Armstrong, M. , Kidd, M. , Brown, M. and Doherty, T. (2013) Hepatitis E is more common than hepatitis A among returning travellers presenting to tertiary care. World Journal of Cardiovascular Diseases, 3, 519-522. doi: 10.4236/wjcd.2013.38082.
[1]   Public Health England, “Hepatitis A Laboratory Reports and Statutory Notifications, England and Wales,” 2010.

[2]   Behrens, R.H., Collins, M., Botto, B. and Heptonstall, J. (1995) Risk for British travellers of acquiring hepatitis A. British Medical Journal, 311, 193.

[3]   Public Health England, 2010.

[4]   Li, L., Zhu, Y., Fu, H., Wei, X., Wang, L., Liang, J., Ji, Y., Tang, R. and Zhuang, H. (2009) Full-genome nucleotide sequence and analysis of a Chinese swine hepatitis E virus isolate of genotype 4 identified in the Guangxi Zhuang autonomous region: Evidence of zoonotic risk from swine to human in South China. Liver International, 29, 1230-1240.

[5]   Public Health England, 2010.

[6]   Shrestha, M.P., Scott, R.M., Joshi, D.M., Mammen, P.M., Thapa, G.B., Thapa, N., et al. (2007) Safety and efficacy of a recombinant hepatitis E vaccine. The New England Journal of Medicine, 356, 895-903.

[7]   Zhu, F.C., Zhang, J., Zhang, X.F., Zhou, C., Wang, Z.Z., Huang, S.J., Wang, H., et al. (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet, 376, 895-902.

[8]   Mushahwar, I.K. (2008) Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. Journal of Medical Virology, 80, 646-658. http://dx.doi.org/10.1002/jmv.21116

[9]   Krawczynski, K. (2007) Hepatitis E vaccine—Ready for prime time? The New England Journal of Medicine, 356, 949-951. http://dx.doi.org/10.1056/NEJMe068311

[10]   Ijaz, S., Arnold, E., Banks, M., Hewitt, K., Ngui, S.L., Boxall, E., et al. (2005) Non-travel-associated hepatitis E in England and Wales: Demographic, clinical, and molecular epidemiological characteristics. The Journal of Infectious Diseases, 192, 1166-1172.

[11]   Dalton, H.R., Thurairajah, P.H., Fellows, H.J., Hussaini, H.S., Mitchell, J., Bendall, R., et al. (2007) Autochthonous hepatitis E in southwest England. Journal of Viral Hepatitis, 14, 304-309.

[12]   De Silva, A.N., Muddu, A.K., Iredale, J.P., Sheron, N., Khakoo, S.I. and Pelosi, E. (2008) Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: Time for routine testing? Journal of Medical Virology, 80, 283-288.

[13]   Bhatia, V., Singhal, A., Panda, S.K. and Acharya, S.K. (2008) A 20-year single-center experience with acute liver failure during pregnancy: Is the prognosis really worse? Hepatology, 48, 1577-1585.

[14]   Dalton, H.R., Bendall, R.P., Keane, F.E., Tedder, R.S. and Ijaz, S. (2009) Persistent carriage of hepatitis E virus in patients with HIV infection. The New England Journal of Medicine, 361, 1025-1027.

[15]   Haagsma, E.B., Niesters, H.G., van den Berg, A.P., Riezebos-Brilman, A., Porte, R.J., Vennema, H., et al. (2009) Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transplantation, 15, 1225-1258.

[16]   Haagsma, E.B., van den Berg, A.P., Porte, R.J., Benne, C.A., Vennema, H., Reimerink, J.H., et al. (2008) Chronic hepatitis E virus infection in liver transplant recipients. Liver Transplantation, 14, 547-553.

[17]   Li, R.C., Ge, S.X., Li, Y.P., Zheng, Y.J., Nong, Y., Guo, Q.S., et al. (2006) Seroprevalence of hepatitis E virus infection, rural southern People’s Republic of China. Emerging Infectious Diseases Journal, 12, 1682-1688.

[18]   Mohanavalli, B., Dhevahi, E., Menon, T., Malathi, S. and Thyagarajan, S.P. (2003) Prevalence of antibodies to hepatitis A and hepatitis E virus in urban school children in Chennai 1. Indian Pediatrics, 40, 328-331.

[19]   Lewis, H.C., Boisson, S., Ijaz, S., Hewitt, K., Ngui, S.L., Boxall, E., et al. (2008) Hepatitis E in England and Wales. Emerging Infectious Diseases Journal, 14, 165-167.